10.1016/J.EJPHAR.2018.10.003 138 MohsenzadehA.PourasgarS.MohammadiA.NazariM.NematollahiS.KarimiY.et al (2025)
They studied patients in SELECT for about 4 years, giving half of them Wegovy and half of them placebo
The choice, when both are options, depends on your health profile, how you respond to medication, cost considerations, and your clinician's judgment
Primary Eye Health Concerns Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) The most significant concern emerging from recent research is the potential increased risk of NAION, a vision-threatening condition that affects the optic nerve
They noted that while the prior study involved patients referred to a single major medical center in a city with a high degree of medical sophistication, our study included individuals from a more general clinical setting. Additionally, they pointed out that differences in population characteristics and drug prescription preferences between single institutions and global databases may contribute to varying results, as can differences in healthcare systems across regions and countries
It produces a single number that places you somewhere on a scale from underweight to severely obese, and that number has become the primary gatekeeper for GLP-1 medication access
/images/2025/03/06/80a97023-8cda-4f9b-9f34-acfd82496b14.png)
